FILTER CONTENT

Filters
Company Names

Research

  • 7investing logo next to the Coherus BioSciences logo.
    By Published On: March 21, 2025

    Sell Coherus BioSciences

  • 7investing logo next to the Avita Medical logo.
    By Published On: February 17, 2025

    AVITA Medical: 2025 Will Be an “Inflection Point Year”

    AVITA Medical is continuing to show signs of progress. Its recently-reported fourth quarter [...]

  • By Published On: November 19, 2024

    November 2024 Conviction Rating Review

  • By Published On: September 19, 2024

    September 2024 Conviction Rating Review

  • By Published On: August 26, 2024

    Here are 3 Key Risks at TransMedics. But the Stock is Still a Buy.

  • By Published On: August 19, 2024

    August 2024 Conviction Rating Review

  • By Published On: July 5, 2024

    NIKE Continues to Navigate a Difficult Fiscal Environment

  • 7investing logo next to the PubMatic logo.
    By Published On: June 27, 2024

    PubMatic is Turning the Corner; Upgrading to Strong Buy

  • 7investing logo next to the BeiGene logo.
    By Published On: February 13, 2024

    BeiGene: Extreme Risk with Extreme Potential Reward. Shares are a “Buy”

  • By Published On: January 12, 2024

    Nike’s Suffering in a Tough Macro; We’re Moving Shares to “Hold”

  • By Published On: December 18, 2023

    7investing’s 2023 Year in Review: An Updated Look at All of Our Stock Picks

  • By Published On: July 12, 2023

    Will SoFi Actually Become a Top 10 US Bank?

  • 7investing logo next to the PubMatic logo.
    By Published On: April 20, 2023

    PubMatic Keeps Winning Market Share

  • Stock market charts with green arrow going up and red arrow going down
    By Published On: January 30, 2023

    SoFi’s Latest Monster Quarter Could Mark an Inflection Point

  • By Published On: December 19, 2022

    7investing’s 2022 Year in Review: An Updated Look at All of Our Stock Picks

  • By Published On: November 22, 2022

    7investing Update: We Are Selling These 9 Stocks